Plasma symmetric dimethylarginine as a metabolite biomarker of severe acute ischemic stroke

被引:0
作者
Pihlasviita, Saana [1 ,2 ]
Mattila, Olli S. [1 ,2 ]
Nukarinen, Tiina [1 ,2 ]
Kuisma, Markku [2 ,3 ]
Harve-Rytsala, Heini [2 ,3 ]
Ritvonen, Juhani [1 ,2 ]
Sibolt, Gerli [1 ,2 ]
Curtze, Sami [1 ,2 ]
Strbian, Daniel [1 ,2 ]
Pystynen, Mikko [2 ,3 ]
Tatlisumak, Turgut [4 ,5 ]
Lindsberg, Perttu J. [1 ,2 ]
机构
[1] Univ Helsinki, Neurol & Clin Neurosci, Helsinki, Finland
[2] Helsinki Univ Hosp, Helsinki, Finland
[3] Univ Helsinki, Dept Emergency Care, Emergency Med & Serv, Helsinki, Finland
[4] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Neurosci Neurol, Inst Neurosci & Physiol, Gothenburg, Sweden
[5] Sahlgrens Univ Hosp, Dept Neurol, Gothenburg, Sweden
来源
FRONTIERS IN NEUROLOGY | 2024年 / 15卷
关键词
stroke; diagnosis; acute management; biomarkers; SDMA; LARGE VESSEL OCCLUSION; ASYMMETRIC DIMETHYLARGININE; RISK MARKER; L-ARGININE; SCALE; DIAGNOSIS; PROTEINS; ADMA; TIA;
D O I
10.3389/fneur.2024.1472424
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: After severe ischemic stroke (IS), circulating levels of symmetric dimethylarginine (SDMA) increase. We investigated the early dynamics of SDMA in stroke to potentially aid with prehospital identification of severe IS from hemorrhagic stroke (HS). Methods: We performed targeted mass spectrometry (MS) measurements of SDMA in two sequential acute plasma samples (early and secondary) of 50 IS patients with LVO and 49 HS patients. Secondary samples of 227 IS and 84 HS patients with moderate to severe symptoms (NIHSS >= 7) subsequently underwent ELISA validation. Results: The median (IQR) last-known-well (LKW) to sampling times were 43 min (35-67) for early samples in the MS analysis, and 83 min (65-113) for secondary samples in MS and ELISA analyses. No inter-group differences existed in early samples, but IS patients had significantly higher mean (IQR) SDMA levels in secondary samples in both analyses: 5.8 (5.3-6.9) vs. 5.1 (4.2-5.8) A.U. for HS, p < 0.001, with MS; and 0.82 (0.72-1.01) vs. 0.71 (0.58-0.85) nmol/mL for HS, p < 0.001, with ELISA. For IS patients, higher SDMA levels were associated with cardioembolic stroke: 0.84 (0.73-1.09) vs. 0.79 (0.71-0.91) nmol/mL for other etiologies, p = 0.042, and poor outcome: modified Rankin Scale (mRS) 4-6; 0.90 (0.73-1.06) vs. 0.80 (0.72-0.97) nmol/mL for mRS 0-3 (p = 0.045). Conclusion: In a large clinical cohort of stroke patients with moderate to severe symptoms, our data suggest that SDMA can assist in differentiation of IS and HS patients already 1 h and a half after symptom onset. SDMA may prove to have future value in a diagnostic stroke biomarker panel.
引用
收藏
页数:11
相关论文
共 50 条
[31]   Association Of Alpha2-macroglobulin As A Novel Biomarker With Acute Ischemic Stroke [J].
Nezu, Tomohisa ;
Hosomi, Naohisa ;
Aoki, Shiro ;
Ohtsuki, Toshiho ;
Yamawaki, Takemori ;
Matsumoto, Masayasu .
STROKE, 2013, 44 (02)
[32]   Increased plasma levels of total homocysteine but not asymmetric dimethylarginine in Hispanic subjects with ischemic stroke FREC-VI sub-study [J].
Rueda-Clausen, C. F. ;
Cordoba-Porras, A. ;
Bedoya, G. ;
Silva, F. A. ;
Zarruk, J. G. ;
Lopez-Jaramillo, P. ;
Villa, L. A. .
EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (03) :417-425
[33]   Multimodality Imaging in Acute Ischemic Stroke [J].
Zameer, Shahla ;
Siddiqui, Ayesha Shamim ;
Riaz, Ramish .
CURRENT MEDICAL IMAGING, 2021, 17 (05) :567-577
[34]   Prediction of conscious awareness recovery after severe acute ischemic stroke [J].
Hu, Yajuan ;
Wang, Changqing ;
Yan, Xiaoxiang ;
Fu, Hong ;
Wang, Kai .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 383 :128-134
[35]   Association of dimethylarginines and mediators of inflammation after acute ischemic stroke [J].
Chen, Shufen ;
Martens-Lobenhoffer, Jens ;
Weissenborn, Karin ;
Kielstein, Jan T. ;
Lichtinghagen, Ralf ;
Deb, Milani ;
Li, Na ;
Tryc, Anita B. ;
Goldbecker, Annemarie ;
Dong, Qiang ;
Bode-Boeger, Stefanie M. ;
Worthmann, Hans .
JOURNAL OF NEUROINFLAMMATION, 2012, 9
[36]   Potential Metabolite Biomarkers for Acute Versus Chronic Stage of Ischemic Stroke: A Pilot Study [J].
Sidorov, Evgeny ;
Bejar, Cynthia ;
Xu, Chao ;
Ray, Bappaditya ;
Reddivari, Lavanya ;
Chainakul, Juliane ;
Vanamala, Jairam K. P. ;
Sanghera, Dharambir K. .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (04)
[37]   Neuronal plasma biomarkers in acute ischemic stroke [J].
Gundersen, Julia K. ;
Gonzalez-Ortiz, Fernando ;
Karikari, Thomas ;
Kirsebom, Bjorn-Eivind ;
Mertes, Katrin ;
Zetterberg, Henrik ;
Kvartsberg, Hlin ;
Ronning, Ole Morten ;
Gisladottir, Berglind ;
Blennow, Kaj ;
Fladby, Tormod .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2025, 45 (01) :77-84
[38]   Cryoglobulinemia and extracorporal plasma therapy in severe ischemic stroke [J].
Skvortsova, VI ;
Konstantinova, NA ;
Zelenkina, LI ;
Komarov, AN ;
Erymin, II ;
Shamalov, NA .
ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2004, :47-51
[39]   Dimethylarginine Levels in Cerebrospinal Fluid of Hyperacute Ischemic Stroke Patients are Associated with Stroke Severity [J].
Raf Brouns ;
Bart Marescau ;
Ilse Possemiers ;
Rishi Sheorajpanday ;
Peter P. De Deyn .
Neurochemical Research, 2009, 34 :1642-1649
[40]   Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke [J].
Ercan, Mujgan ;
Mungan, Semra ;
Guzel, Isil ;
Celik, Huseyin Tugrul ;
Bal, Ceylan ;
Abusoglu, Sedat ;
Akbulut, Deniz ;
Oguz, Esra Firat ;
Yilmaz, Fatma Meric .
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 28 (05) :693-698